Correlates of Antiviral Immune Restoration in Acute and Chronic HIV Type 1 Infection: Sustained Viral Suppression and Normalization of T Cell Subsets
- 20 September 2002
- journal article
- clinical trial
- Published by Mary Ann Liebert Inc in AIDS Research and Human Retroviruses
- Vol. 18 (14) , 999-1010
- https://doi.org/10.1089/08892220260235362
Abstract
Highly active antiretroviral therapy (HAART) has suppressed viral replication and facilitated normalization of T cell subsets, resulting in restoration of immunity against opportunistic pathogens. Induction of full immune restoration in chronically infected individuals, including HIV-specific helper T cell responses, is considered a priority, particularly if immunological control of HIV is to be achieved. Regimens containing dual protease inhibitors (PIs) have provided greater suppression of viremia than single-PI regimens. We therefore conducted a prospective analysis of factors associated with immune restoration after 3 years of therapy in two cohorts of acutely and chronically HIV-infected patients, comparing dual- versus single-PI regimens. Earlier and more durable returns of p24-specific proliferation were demonstrated in patients receiving dual-PI compared with single-PI regimens. Individuals with restored p24 responses had larger reductions in total HIV-specific cytotoxic T lymphocytes (CTLs) associated with stronger viral suppression, but Gag-specific CTLs remained higher, demonstrating that Gag-specific helper T cell responses were a critical component of functional immune restoration. On examination of clinical factors associated with immune restoration, we demonstrated that decreasing activation of CD8+ T cells (%CD8+ CD38+) and increasing proportions of CD4+ T cells were independently associated with restoration of p24 responses. Minimal immune activation, resulting from maximal suppression of viral replication, was required for long-term restoration and maintenance of Gag-specific T cell responses. This study uniquely demonstrates that dual-PI regimens are superior in achieving these levels of virological control and immune restoration in both chronic and acute infection, compared with single-PI or non-PI regimens.Keywords
This publication has 50 references indexed in Scilit:
- Progressive Human Immunodeficiency Virus–Specific Immune Recovery with Prolonged Viral SuppressionThe Journal of Infectious Diseases, 2001
- Proliferative Responses to Human Immunodeficiency Virus Type 1 (HIV‐1) Antigens in HIV‐1–Infected Patients with Immune ReconstitutionThe Journal of Infectious Diseases, 2001
- Highly Active Antiretroviral Therapy Results in HIV Type 1 Suppression in Lymph Nodes, Increased Pools of Naive T Cells, Decreased Pools of Activated T Cells, and Diminished Frequencies of Peripheral Activated HIV Type 1-Specific CD8+T CellsAIDS Research and Human Retroviruses, 2000
- High Frequency of Cytomegalovirus‐Specific Cytotoxic T‐Effector Cells in HLA‐A*0201–Positive Subjects during Multiple Viral CoinfectionsThe Journal of Infectious Diseases, 2000
- Potent Antiretroviral Therapy of Primary Human Immunodeficiency Virus Type 1 (HIV‐1) Infection: Partial Normalization of T Lymphocyte Subsets and Limited Reduction of HIV‐1 DNA Despite Clearance of Plasma ViremiaThe Journal of Infectious Diseases, 1999
- CD8+Anti–Human Immunodeficiency Virus Suppressor Activity (CASA) in Response to Antiretroviral Therapy: Loss of CASA Is Associated with Loss of ViremiaThe Journal of Infectious Diseases, 1999
- Quantitation of HIV-1-Specific Cytotoxic T Lymphocytes and Plasma Load of Viral RNAScience, 1998
- RitonavirClinical Pharmacokinetics, 1998
- Decay characteristics of HIV-1-infected compartments during combination therapyNature, 1997
- Elevated relative fluorescence intensity of CD38 antigen expression on CD8 T cells is a marker of poor prognosis in HIV infection: Results of 6 years of follow‐upCytometry, 1996